Bridgeway Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$105K	Hold	143,000	–	–	﹤0.01%	1065
2025 Q1	$115K	Sell	143,000 -60,000	-30%	-$48.4K	﹤0.01%	1010
2024 Q4	$280K	Sell	203,000 -109,700	-35%	-$151K	0.01%	939
2024 Q3	$325K	Buy	312,700 +69,700	+29%	+$72.5K	0.01%	962
2024 Q2	$420K	Buy	+243,000	New	+$420K	0.01%	896